Skip to content

High- Versus Low-calcium Water for Bone Health

Metabolic Response to the Consumption of Waters With Different Calcium Content: a Cross-over Clinical Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05772364
Enrollment
41
Registered
2023-03-16
Start date
2023-03-02
Completion date
2026-04-23
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Resorption, Calcium Metabolism Disorders, Eating, Healthy, Orthopedic Disorder, Water-Electrolyte Imbalance

Brief summary

The experimental study investigates which metabolic responses of calcium and parathyroid hormone are observable in blood and urine in a cohort of 41 healthy adults following a sequence of different exposures: low-calcium water first and high-calcium water afterward.

Interventions

OTHERLoading of low-calcium water first, then high-calcium water

All cohort subjects are asked to consume water with less than 5 mg/L of calcium first, then are asked to consume water with at least 400 mg/L of calcium

Sponsors

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index ≥ 18 and \< 30 * Maintenance of diet and physical activity lifestyle throughout the duration of the study * Acceptance of informed consent

Exclusion criteria

* Consumption of water with calcium \> 150 mg/L * Pregnancy (as established by self-declaration), breastfeeding, menopause * Inability to follow the study protocol * Cardiac, vascular, renal, and oncological disease * Neuropsychiatric disease, developmental disorders * Disease or past surgery affecting the gastrointestinal tract * Drugs that interfere with bone (e.g. corticosteroids) or with fluid balance (e.g. diuretics)

Design outcomes

Primary

MeasureTime frameDescription
Change of blood calcium levelsBaseline and 2.5 hoursChange of calcium levels (mg/dL) from baseline and after 2.5 hours

Countries

Italy

Contacts

PRINCIPAL_INVESTIGATORMatteo Briguglio

IRCCS Istituto Ortopedico Galeazzi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026